Moderna, Inc. (MRNA)

Moderna, Inc. trades on Nasdaq under the ticker MRNA. The company belongs to the Health care sector. The trading history on this page starts on 7 December 2018.

Over the past 52 weeks MRNA has traded between 22.28 $ and 227.46 $. As of 30 October 2026 the price stood 99.43 % of the way from the 52-week low to the high.

Over one year MRNA shares rose 762.10 %; over six months they rose 317.07 %. Volatility over 90 days is 193.23 %. Dividends are not included: this is price change only, as of 30 October 2026.

The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 39.4, above the sector median of 3.6. Price to book is 13.0, above the sector median of 2.5. Calculated from reports for the period ending 30 June 2026.

Moderna, Inc. reported revenue of 2.2B $ and a net loss of 3.2B $ over the last four quarters. Net margin is −141.43 %. Revenue changed by −27.62 % year over year. Earnings per share are −7.98 $. Market capitalisation is 87.9B $.

MRNA has a return on equity of −46.61 %, below the sector median of −40.58 %. Return on assets is −28.75 %, above the sector median of −30.08 %. Operating margin is −149.01 %, below the sector median of −20.96 %.